ProShares UltraShort Nasdaq Biotech (BIS)

Add to Watchlists
Create an Alert
42.56 -1.01  -2.32% NASDAQ Dec 19, 8:00PM BATS Real time Currency in USD
View Full Chart
BIS Price Chart

BIS Description

ProShares UltraShort Nasdaq Biotech is a long-short equity fund managed by ProShares that tracks the NASDAQ Biotechnology TR USD index and has 47.38M USD assets under management. The fund has a net expense ratio of 0.95% and is traded on the NASDAQ.

BIS Key Info

Expense Ratio (10-1-14) 0.95%
Assets Under Management (12-18-14) 47.38M
30-Day Average Volume (12-19-14) 135170.2
Net Asset Value (12-18-14) 43.67
Discount or Premium to NAV (12-19-14) -0.49%
Turnover Ratio --
View All BIS News

BIS News

BIS Asset Allocation

Type % Net % Long % Short
Cash 299.7% 299.7% 0.00%
Stock -199.6% 0.15% 199.8%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.09% 0.00% 0.09%
As of Sept. 30, 2014

BIS Region Exposure

Americas --
North America --
Latin America --
Greater Europe --
United Kingdom --
Europe Developed --
Europe Emerging --
Africa/Middle East --
Greater Asia --
Japan --
Australasia --
Asia Developed --
Asia Emerging --
Market Classification
% Developed Markets --
% Emerging Markets --
Date Unavailable
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIS Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Sept. 30, 2014

BIS Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of Sept. 30, 2014

BIS Top 10 Holdings

Name % Weight Price Chg %
Nasdaq Biotechnology Index Swap Bank Of America, Na 79.63% -- --
Nasdaq Biotechnology Index Swap Societe Generale 66.98% -- --
Nasdaq Biotechnology Index Swap Ubs Ag 41.29% -- --
Nasdaq Biotechnology Index Swap Deutsche Bank Ag 6.29% -- --
Nasdaq Biotechnology Index Swap Credit Suisse International 5.37% -- --
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc 0.15% -- --
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc - Ca 0.15% -- --
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 0.07% -- --
Nasdaq Biotechnology Index Swap Citibank, N.A. 0.04% -- --
Ishares Biotech (Ibb) Swap Bank Of America, Na 0.02% -- --
As of Sept. 30, 2014
Get Quote for
Advertisement

BIS Basic Info

Style
Asset Class Alternative
Prospectus Objective Specialty - Health
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD -200.0%
Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2014
Last Prospectus Date 10/1/2014
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund Yes
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund Yes
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

BIS Manager Info

Name Tenure
Charles Lowery 1.08 yrs
Michael Neches 1.08 yrs

BIS Risk Info

Beta -1.735
30 Day Average Volatility 47.92%

BIS Fundamentals

Dividend Yield TTM (12-19-14) 0.00%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield --
Forecasted PE Ratio --
Forecasted Price to Sales Ratio --
Forecasted Price to Book Ratio --
Number of Holdings 8.000
As of Sept. 30, 2014

BIS Growth Estimates

Forecasted 5 Yr Earnings Growth --
Forecasted Book Value Growth --
Forecasted Cash Flow Growth --
Forecasted Earnings Growth --
Forecasted Revenue Growth --
As of Sept. 30, 2014

BIS Performance

  Returns Total Returns
1M -15.49% -15.49%
3M -28.95% -28.95%
6M -43.37% -43.37%
1Y -62.14% -62.14%
3Y -94.09% -94.09%
5Y -- --
As of Dec. 18, 2014

BIS Flows

1M -5.899M
3M -10.48M
6M 21.71M
YTD 76.98M
1Y 76.98M
3Y 91.88M
5Y --
As of Nov. 30, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.